IDEX Corporation (IEX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IEX SEC filings page.
IDEX Corporation (IEX) reported $3.6B in revenue over the twelve months to Jun 30, 2026, up 7.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Stable gross margins mask rising overhead and financing costs, while cash generation remains strong enough to fund reinvestment and shareholder distributions.
In FY2025, revenue rose5.8% while gross margin held at44.5% , showing that added sales did not materially change the product economics. Yet net margin was14.0% while free cash flow reached$616.8M despite lower net income, indicating that noncash expenses meaningfully support cash conversion even as reported profitability weakens.
The balance sheet is increasingly goodwill-heavy: goodwill was
Free cash flow of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of IDEX Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
IDEX Corporation has an operating margin of 20.2%, meaning the company retains $20 of operating profit per $100 of revenue. This strong profitability earns a score of 89/100, reflecting efficient cost management and pricing power. This is down from 20.7% the prior year.
IDEX Corporation's revenue grew 5.8% year-over-year to $3.5B, a solid pace of expansion. This earns a growth score of 41/100.
IDEX Corporation has a moderate D/E ratio of 0.45. This balance of debt and equity financing earns a leverage score of 40/100.
With a current ratio of 2.86, IDEX Corporation holds $2.86 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 77/100.
IDEX Corporation converts 17.8% of revenue into free cash flow ($616.8M). This strong cash generation earns a score of 84/100.
IDEX Corporation earns a strong 12.0% return on equity (ROE), meaning it generates $12 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 77/100. This is down from 13.3% the prior year.
IDEX Corporation scores 5.50, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($17.3B) relative to total liabilities ($2.9B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
IDEX Corporation passes 8 of 9 financial strength tests. 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, IDEX Corporation generates $1.41 in operating cash flow ($680.4M OCF vs $483.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
IDEX Corporation earns $10.86 in operating income for every $1 of interest expense ($699.3M vs $64.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
IDEX Corporation generated $920.6M in revenue in Q2 2026. This represents an increase of 6.4% from the same quarter a year earlier. Against the prior quarter it is up 3.8%.
IDEX Corporation's EBITDA was $253.3M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.0% from the same quarter a year earlier. Against the prior quarter it is up 12.0%.
IDEX Corporation reported $143.4M in net income in Q2 2026. This represents an increase of 9.0% from the same quarter a year earlier. Against the prior quarter it is up 19.5%.
IDEX Corporation earned $1.93 per diluted share (EPS) in Q2 2026. This represents an increase of 10.9% from the same quarter a year earlier. Against the prior quarter it is up 19.9%.
Cash & Balance Sheet
IDEX Corporation generated $177.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 20.5% from the same quarter a year earlier. Against the prior quarter it is up 105.8%.
IDEX Corporation held $621.3M in cash against $1.9B in long-term debt as of Q2 2026.
IDEX Corporation paid $1.46 per share in dividends in Q2 2026. This represents an increase of 2.8% from the same quarter a year earlier.
Margins & Returns
IDEX Corporation's gross margin was 46.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.
IDEX Corporation's operating margin was 21.7% in Q2 2026, reflecting core business profitability. That is unchanged from the same quarter a year earlier. Against the prior quarter it is up 2.3 percentage points.
IDEX Corporation's net profit margin was 15.6% in Q2 2026, showing the share of revenue converted to profit. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.0 percentage points.
IDEX Corporation's ROE was 3.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.
Capital Allocation
IDEX Corporation spent $77.1M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 54.2% from the same quarter a year earlier. Against the prior quarter it is up 1.0%.
IDEX Corporation invested $23.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 55.4% from the same quarter a year earlier. Against the prior quarter it is up 29.9%.
Not reported for Q2 2026.
IEX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $920.6M+6.4% | $886.9M+8.9% | $899.1M+4.2% | $878.7M+10.1% | $865.4M+7.2% | $814.3M+1.7% | $862.9M+9.4% | $798.2M+0.6% |
| Cost of Revenue | $493.8M+4.4% | $488.8M+9.7% | $512.0M+3.3% | $488.1M+9.9% | $473.2M+7.4% | $445.4M+0.5% | $495.8M+9.7% | $444.3M+0.1% |
| Gross Profit | $426.8M+8.8% | $398.1M+7.9% | $387.1M+5.4% | $390.6M+10.4% | $392.2M+6.9% | $368.9M+3.2% | $367.1M+9.0% | $353.9M+1.2% |
| SG&A Expenses | $224.1M+10.1% | $218.3M+4.3% | $201.1M+1.6% | $204.7M+11.9% | $203.6M+11.4% | $209.4M+7.3% | $197.9M+14.0% | $182.9M+10.2% |
| Operating Income | $199.9M+6.4% | $172.4M+21.4% | $183.6M+11.1% | $185.8M+10.6% | $187.9M+2.8% | $142.0M-11.9% | $165.3M+3.0% | $168.0M-6.5% |
| EBITDA | $253.3M+6.0% | $226.1M+17.8% | $237.1M-1.5% | $237.9M+12.3% | $238.9M+7.2% | $191.9M+8.2% | $240.6M+7.6% | $211.9M-2.8% |
| Interest Expense | $15.1M-3.2% | $16.0M-0.6% | $16.2M-3.0% | $16.5M+60.2% | $15.6M+92.6% | $16.1M+71.3% | $16.7M+44.0% | $10.3M-24.8% |
| Income Tax | $42.7M+10.1% | $37.1M+27.5% | $39.4M+40.7% | $42.8M+20.6% | $38.8M+2.1% | $29.1M-12.3% | $28.0M-12.2% | $35.5M-32.8% |
| Net Income | $143.4M+9.0% | $120.0M+25.7% | $128.3M+4.1% | $127.8M+7.3% | $131.6M-6.9% | $95.5M-21.3% | $123.2M+13.4% | $119.1M-43.0% |
| EPS (Basic) | $1.94+11.5% | $1.61+27.8% | $1.71+4.9% | $1.70+8.3% | $1.74-6.5% | $1.26-21.3% | $1.63+14.0% | $1.57-43.1% |
| EPS (Diluted) | $1.93+10.9% | $1.61+27.8% | $1.71+5.6% | $1.70+8.3% | $1.74-6.5% | $1.26-21.3% | $1.62+13.3% | $1.57-42.9% |
| Diluted Shares (Avg) | 74M-1.7% | 74M-1.8% | N/A | 75M-0.9% | 76M-0.5% | 76M-0.1% | N/A | 76M0.0% |
Not reported in any period shown, so not listed: R&D Expenses.
IEX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.9B+0.8% | $6.9B+1.8% | $6.9B+2.7% | $7.0B0.0% | $6.9B+16.5% | $6.8B+15.4% | $6.7B+15.0% | $7.0B+22.9% |
| Current Assets | $1.8B+9.7% | $1.7B+5.5% | $1.6B+3.2% | $1.7B-1.4% | $1.6B-0.8% | $1.6B+4.6% | $1.6B+10.1% | $1.7B+10.5% |
| Cash & Equivalents | $621.3M+9.3% | $586.2M-1.3% | $580.0M-6.6% | $593.8M-6.2% | $568.2M-18.9% | $594.1M-3.6% | $620.8M+16.2% | $633.2M+12.5% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $520.3M+6.7% | $501.0M+7.4% | $479.4M+11.6% | $495.1M+1.4% | $487.8M+14.0% | $466.3M+9.5% | $429.7M+2.1% | $488.2M+9.3% |
| Accounts Receivable | $544.3M+16.2% | $544.5M+14.6% | $511.9M+11.0% | $488.7M+4.6% | $468.5M+12.6% | $475.3M+10.8% | $461.0M+10.0% | $467.3M+10.5% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $3.4B+0.4% | $3.4B+3.1% | $3.4B+5.0% | $3.4B+2.8% | $3.4B+20.9% | $3.3B+17.3% | $3.3B+14.6% | $3.3B+23.9% |
| Total Liabilities | $2.9B+2.0% | $2.9B-0.7% | $2.9B-1.7% | $3.0B-6.0% | $2.9B+27.4% | $2.9B+27.2% | $3.0B+27.0% | $3.1B+38.0% |
| Current Liabilities | $581.6M+9.8% | $506.0M-13.3% | $575.4M-8.6% | $564.0M-0.1% | $529.8M+11.0% | $583.6M+26.7% | $629.7M+25.9% | $564.6M+15.8% |
| Non-Current Liabilities | $2.3B+0.3% | $2.4B+2.5% | $2.3B+0.2% | $2.4B-7.3% | $2.3B+31.8% | $2.3B+27.3% | $2.3B+27.3% | $2.6B+44.0% |
| Long-Term Debt | $1.9B+0.6% | $1.9B+1.8% | $1.8B-2.1% | $1.9B-8.4% | $1.8B+42.4% | $1.8B+39.0% | $1.9B+40.3% | $2.1B+57.1% |
| Total Equity | $4.0B-0.1% | $4.0B+3.7% | $4.0B+6.1% | $4.0B+5.0% | $4.0B+9.8% | $3.9B+8.0% | $3.8B+7.2% | $3.8B+12.7% |
| Retained Earnings | $4.7B+7.0% | $4.6B+6.8% | $4.5B+6.4% | $4.4B+6.4% | $4.4B+6.3% | $4.3B+6.7% | $4.2B+7.5% | $4.2B+7.4% |
IEX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $200.0M+23.7% | $103.7M-1.9% | $209.5M+21.4% | $203.5M-0.9% | $161.7M+21.0% | $105.7M-32.5% | $172.6M-14.1% | $205.3M-9.4% |
| Depreciation & Amortization | $53.4M+4.7% | $53.7M+7.6% | $53.5M+5.5% | $52.1M+18.7% | $51.0M+26.9% | $49.9M+208.0% | $50.7M+28.0% | $43.9M+14.0% |
| Stock-Based Compensation | $8.2M+41.4% | $15.8M+16.2% | N/A | $5.5M+5.8% | $5.8M+41.5% | $13.6M+8.8% | N/A | $5.2M+108.0% |
| Capital Expenditures | $23.0M+55.4% | $17.7M+23.8% | $19.7M+27.1% | $14.8M+8.0% | $14.8M-6.9% | $14.3M-28.5% | $15.5M-28.2% | $13.7M-31.8% |
| Free Cash Flow | $177.0M+20.5% | $86.0M-5.9% | $189.8M+20.8% | $188.7M-1.5% | $146.9M+24.8% | $91.4M-33.1% | $157.1M-12.4% | $191.6M-7.2% |
| Investing Cash Flow | -$22.3M-53.8% | -$20.4M-104.0% | -$17.6M-19.7% | -$95.5M+90.5% | -$14.5M-145.7% | -$10.0M+50.0% | -$14.7M+92.4% | -$1.0B-1258.8% |
| Financing Cash Flow | -$139.3M+35.5% | -$68.8M+48.4% | -$207.7M-47.5% | -$75.7M-110.4% | -$215.9M-179.7% | -$133.3M-225.1% | -$140.8M-142.8% | $724.9M+472.3% |
| Dividends Paid | $53.9M+0.7% | $52.8M+0.8% | $53.2M+1.7% | $53.5M+2.3% | $53.5M+2.5% | $52.4M+8.0% | $52.3M+8.1% | $52.3M+8.1% |
| Share Buybacks | $77.1M+54.2% | $76.3M+52.6% | $72.8M | $75.0M | $50.0M | $50.0M | $0-100.0% | $0-100.0% |
IEX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.4%+1.0pp | 44.9%-0.4pp | 43.0%+0.5pp | 44.5%+0.1pp | 45.3%-0.1pp | 45.3%+0.7pp | 42.5%-0.2pp | 44.3%+0.3pp |
| Operating Margin | 21.7%0.0pp | 19.4%+2.0pp | 20.4%+1.3pp | 21.1%+0.1pp | 21.7%-0.9pp | 17.4%-2.7pp | 19.2%-1.2pp | 21.1%-1.6pp |
| Net Margin | 15.6%+0.4pp | 13.5%+1.8pp | 14.3%0.0pp | 14.5%-0.4pp | 15.2%-2.3pp | 11.7%-3.4pp | 14.3%+0.5pp | 14.9%-11.4pp |
| Return on Equity | 3.6%+0.3pp | 3.0%+0.5pp | 3.2%-0.1pp | 3.2%+0.1pp | 3.3%-0.6pp | 2.4%-0.9pp | 3.3%+0.2pp | 3.1%-3.0pp |
| Return on Assets | 2.1%+0.2pp | 1.7%+0.3pp | 1.8%0.0pp | 1.8%+0.1pp | 1.9%-0.5pp | 1.4%-0.7pp | 1.8%0.0pp | 1.7%-2.0pp |
| Current Ratio | 3.050.0x | 3.39+0.6x | 2.86+0.3x | 2.930.0x | 3.05-0.4x | 2.79-0.6x | 2.53-0.4x | 2.97-0.1x |
| Debt-to-Equity | 0.460.0x | 0.460.0x | 0.450.0x | 0.47-0.1x | 0.46+0.1x | 0.47+0.1x | 0.49+0.1x | 0.54+0.2x |
| Asset Turnover | 0.130.0x | 0.130.0x | 0.130.0x | 0.130.0x | 0.130.0x | 0.120.0x | 0.130.0x | 0.110.0x |
| FCF Margin | 19.2%+2.3pp | 9.7%-1.5pp | 21.1%+2.9pp | 21.5%-2.5pp | 17.0%+2.4pp | 11.2%-5.8pp | 18.2%-4.5pp | 24.0%-2.0pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| IDEX Corporation IEX | FY2025 | $3.5B | $483.2M | 14.0% | $17.3B | 68/100 |
| Graco Inc GGG | FY2025 | $2.2B | $521.8M | 23.3% | $12.7B | 77/100 |
| Nordson Corp NDSN | FY2025 | $2.8B | $484.5M | 17.3% | $18.2B | 63/100 |
| Crane Company CR | FY2025 | $2.3B | $366.6M | 15.9% | $11.7B | 56/100 |
| ITT Inc. ITT | FY2025 | $3.9B | $488.0M | 12.4% | $17.8B | 80/100 |
| A.O. Smith Corporation AOS | FY2025 | $3.8B | $546.2M | 14.3% | $7.7B | 68/100 |
Where IDEX Corporation Ranks
Frequently Asked Questions
What is IDEX Corporation's annual revenue?
IDEX Corporation (IEX) reported $3.5B in total revenue for fiscal year 2025. This represents a 5.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is IDEX Corporation's revenue growing?
IDEX Corporation (IEX) revenue grew by 5.8% year-over-year, from $3.3B to $3.5B in fiscal year 2025.
Is IDEX Corporation profitable?
Yes, IDEX Corporation (IEX) reported a net income of $483.2M in fiscal year 2025, with a net profit margin of 14.0%.
What is IDEX Corporation's EBITDA?
IDEX Corporation (IEX) had EBITDA of $905.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does IDEX Corporation have?
As of fiscal year 2025, IDEX Corporation (IEX) had $580.0M in cash and equivalents against $1.8B in long-term debt.
What is IDEX Corporation's gross margin?
IDEX Corporation (IEX) had a gross margin of 44.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is IDEX Corporation's operating margin?
IDEX Corporation (IEX) had an operating margin of 20.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is IDEX Corporation's net profit margin?
IDEX Corporation (IEX) had a net profit margin of 14.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does IDEX Corporation pay dividends?
Yes, IDEX Corporation (IEX) paid $2.84 per share in dividends during fiscal year 2025.
What is IDEX Corporation's return on equity (ROE)?
IDEX Corporation (IEX) has a return on equity of 12.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is IDEX Corporation's free cash flow?
IDEX Corporation (IEX) generated $616.8M in free cash flow during fiscal year 2025. This represents a 2.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is IDEX Corporation's operating cash flow?
IDEX Corporation (IEX) generated $680.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are IDEX Corporation's total assets?
IDEX Corporation (IEX) had $6.9B in total assets as of fiscal year 2025, including both current and long-term assets.
What are IDEX Corporation's capital expenditures?
IDEX Corporation (IEX) invested $63.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does IDEX Corporation spend on research and development?
IDEX Corporation (IEX) invested $70.0M in research and development during fiscal year 2025.
What is IDEX Corporation's current ratio?
IDEX Corporation (IEX) had a current ratio of 2.86 as of fiscal year 2025, which is generally considered healthy.
What is IDEX Corporation's debt-to-equity ratio?
IDEX Corporation (IEX) had a debt-to-equity ratio of 0.45 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is IDEX Corporation's return on assets (ROA)?
IDEX Corporation (IEX) had a return on assets of 7.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is IDEX Corporation's P/E ratio?
IDEX Corporation (IEX) trades at 33.2x earnings, its market capitalization divided by net income of $519.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $17.3B as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is IDEX Corporation's price-to-sales ratio?
IDEX Corporation (IEX) trades at 4.8x sales, its market capitalization divided by revenue of $3.6B revenue, trailing 12 months to June 30, 2026. The market capitalization is $17.3B as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is IDEX Corporation's Altman Z-Score?
IDEX Corporation (IEX) has an Altman Z-Score of 5.50, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is IDEX Corporation's Piotroski F-Score?
IDEX Corporation (IEX) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are IDEX Corporation's earnings high quality?
IDEX Corporation (IEX) has an earnings quality ratio of 1.41x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can IDEX Corporation cover its interest payments?
IDEX Corporation (IEX) has an interest coverage ratio of 10.86x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is IDEX Corporation?
IDEX Corporation (IEX) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.